Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma

Cancer Research

Volumn 62, Issue 18, 2002, Pages 5223-5229

  Ding, Wei Qun ^a   Cheng, Zhi Jie ^a   McElhiney, Judy ^a   Kuntz, Susan M ^a   Miller, Laurence J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COMPLEMENTARY DNA; MESSENGER RNA; RECEPTOR; SECRETIN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CHO CELL; CONTROLLED STUDY; DIMERIZATION; EXON; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

ALTERNATIVE SPLICING; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL DIVISION; CHO CELLS; CLONING, MOLECULAR; COS CELLS; CRICETINAE; CYCLIC AMP; DIMERIZATION; HUMANS; PANCREATIC NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SECRETIN; TUMOR CELLS, CULTURED; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0037105663     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma
2. Adenocarcinoma of the human exocrine pancreas: Presence of secretin and caerulein receptors
3. Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation
4. Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990
5. Secretin inhibits growth and mitogen-activated protein kinase activation in recombinant secretin receptor-bearing pancreatic adenocarcinoma-derived cells
6. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells
7. Pancreatic carcinogenesis: Effect of secretin in the hamster-nitrosamine model
8. Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein-coupled receptors
9. VIP regulation of a human pancreatic cancer cell line: Capan-1
10. 1 receptor activation
11. Establishment of a continuous tumor-cell line (Panc-1) from a human carcinoma of the exocrine pancreas
12. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: Sensitivity to asparaginase
13. A new human pancreatic carcinoma cell line developed for adoptive immunotherapy studies with lymphokine-activated killer cells in nude mice
14. Sensitivity of xenografts of human pancreatic adenocarcinoma in nude mice to heat and heat combined with chemotherapy
15. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer
16. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis
17. Isolation of messenger RNA from membrane-bound polysomes
18. Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors
19. Forskolin: A specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action
20. Forskolin carbamates: Binding and activation studies with type I adenylyl cyclase
21. Molecular cloning and functional expression of a human pancreatic secretin receptor
22. G-protein-coupled receptors function as oligomers in vivo
23. Identification and molecular characterization of m3 muscarinic receptor dimers
24. Dimerization of the δ opioid receptor: Implication for a role in receptor internalization
25. Molecular cloning and expression of a cDNA encoding the secretin receptor
26. Exocrine pancreatic secretion in the Syrian golden hamster Mesocricetus auratus. II. Effect of secretin and pancreozymin
27. Growth and function of isolated canine pancreatic ductal cells
28. A misspliced form of the CCK-B receptor in pancreatic carcinoma: Role of reduced cellular U2AF35 and a sub-optimal 3′;-splicing site leading to retention of the fourth intron
29. Aberrant splicing but not mutations of TSG101 in human breast cancer
30. Altered expression of the WT1 Wilms’ tumor suppressor gene in human breast cancer
31. Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer
32. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis
33. Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors
34. Role of N-linked glycosylation on the function and expression of the human secretin receptor
35. Demonstration of a direct interaction between residue 22 in the carboxyl-terminal half of secretin and the amino-terminal tail of the secretin receptor using photoaffinity labeling
36. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor
37. Dual contacts between peptide agonist ligands and the secretin receptor directly established by photoaffinity labeling
38. A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation
39. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
40. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
41. Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function
42. G-protein-coupled receptor heterodimerization modulates receptor function
43. Structural insights into the amino-terminus of the secretin receptor. I. Status of cysteine and cystine residues